Search the Blog
Submit
Displaying 21 - 30 of 484 blog posts

Making a Difference

BC Cancer Foundation donors provide crucial support for clinical care and research to improve the outcome of lung cancer patients. For example, through the generous support of donors, we were able to renovate the Endoscopy Suite at the BC Cancer Agency’s Vancouver Centre to install a sophisticated image management system, and acquire the latest endoscopic ultrasound equipment and different types of instruments for biopsy. This first class facility enables us to have a rapid diagnostic clinic. When patients suspected to have lung cancer are referred to us, we can offer a one-stop visit with a...

Finding the Source

I am a Respiratory Medicine specialist looking after patients with lung cancer and a Distinguished Scientist at the BC Cancer Agency Research Center. I lead a team of interventional pulmonologists with highly specialized skills to provide a rapid access service to diagnose lung cancer and determine the stage. We utilize highly technical equipment, including a computerized navigation system and endoscopic ultrasound probes to localize small lesions that are beyond the visible range of a conventional bronchoscope to take a biopsy. We also use ultrasound bronchoscopy to sample lymph glands...

Pioneering path in lung cancer research

I grew up in Hong Kong, and came to Canada when I was 17 to do my undergrad and medical school education at the University of Toronto. After graduation, I came to Vancouver to do my residency training in Internal Medicine and Respiratory Medicine at UBC and then post-fellowship training at the Massachusetts General Hospital, in Boston and the National Cancer Center Hospital in Tokyo. I met my wife, May Ong, at Vancouver General Hospital when we were in training. She is also a University of Toronto medical school graduate. When I was in medical school, one of the health care epidemiology...

Introducing October Guest Blogger: Dr. Stephen Lam

I am delighted to introduce Dr. Stephen Lam as this month’s guest blogger. Dr. Lam is the chair of the Provincial Lung Tumour Group, and directs the MDS-Rix Early Lung Cancer Detection and Translational Research Program at the BC Cancer Agency. His research interest is in early detection, chemoprevention and endoscopic therapy of lung cancer. He has received numerous awards for his pioneering contributions to the field of early lung cancer diagnosis, including the Distinguished Achievement Award from the University of British Columbia and the Joseph Cullen Award for life-time scientific...

Building a Better Patient Experience

As most people know the population in the Fraser Health region, in particular Surrey, is steadily growing. This has provided some wonderful opportunities for residents, but also presents a number of significant challenges for health care delivery in the region. This is not a new problem, indeed the rapid growth of the population and the increasing cancer care needs led to the opening of the Abbotsford Centre eight years ago, along with the new Abbotsford Regional Hospital. Up until that point, people in Abbotsford and the surrounding area needed to travel to Surrey to receive their care at...

It takes a team to deliver great care

I recently accepted the role of Medical Director at the BC Cancer Agency’s Fraser Valley Centre. There are six such Centres across the province, and each now has a Medical Director that works closely with an Operations Director to oversee cancer care. Cancer care is complex and each Centre has many affiliated health care professionals working together—medical oncologists, radiation oncologists, pain and symptom management physicians, gynecologic surgical oncologists, dermatologists, oral oncologists (dentists), nurses, pharmacists, counsellors and psychiatrists, nutritionists, clerks,...

Inspired by cancer care

I am the Medical Director at the BC Cancer Agency’s Fraser Valley Centre. We are very excited at the Centre to be working with the BC Cancer Foundation to fundraise for the expansion of our chemotherapy unit. Surrey, and surrounding communities, make up one of the fastest growing regions in Canada, and to be able to serve the cancer patients in our region we need to expand into a larger space. This will allow us to treat more patients. In upcoming posts I will provide more details about the expansion, and why it is needed. I started working as a Medical Oncologist at the Fraser Valley Centre...

Introducing September Guest Blogger: Dr. Gary Pansegrau

I am delighted to introduce Dr. Gary Pansegrau, as this month’s guest blogger. Dr. Pansegrau is the Regional Leader, Medical Oncology, at the BC Cancer Agency Fraser Valley Centre. Follow along as he shares more about his work, primarily focused on breast cancer, and why the planned expansion of the Fraser Valley Centre will be good news for patients. To support this exciting expansion and renovation project of the Fraser Valley Centre, the BC Cancer Foundation is embarking on a $1 million fundraising initiative. The expansion will boost the Centre’s capacity, allowing it to meet the...

The future of cancer care looks bright

Over the past few weeks I have tried to provide some insight into the exciting immunotherapy research going on at the Deeley Research Centre, as well as the fundraising progress of the Cell Cyclists . For my final post, I thought that I would provide some insight into the future of immunotherapy at the Deeley Research Centre. Currently, the major focus in cancer care and research is how to develop better, targeted treatments that can improve patient survival rates. You can think of cancer as a cluster of different but related cells that have evolved over time. This evolution and diversity of...

Cycling for Research

August seems to be flying by! As you may have heard, the BC Cancer Agency’s Deeley Research Centre is initiating an immunotherapy clinical trial next year. This type of therapy involves isolating tumour-specific white blood cells called T cells from a patient’s own tumour. These T cells are then expanded into the billions and then infused back into the patient where they can identify and eliminate their cancer. This type of therapy is called “adoptive T cell therapy”, and will initially focus on ovarian and cervical cancers. As I previously mentioned, myself and a group of researchers from...

Pages